New News information at World Pharmaceutical Frontiers New and updated information from News listed on en-us New News information at World Pharmaceutical Frontiers Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom by <br/> <br/> SHORT HILLS, NJ. June 16, 2022--(BUSINESS WIRE)-- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ today announced  it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (UK) for lenzilumab. Under the agreement, PCI will purchase lenzilumab for resale and distribution in the event a Conditional Marketing Authorization is received in the UK for use in patients hospitalized with COVID-19. Thu, 16 Jun 2022 11:44:00 GMT Scorpion Biological Services Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer (CEO) by <br/> <br/> Manhattan, KS (USA) – June 14, 2022 –– Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract research organization (CRO), today announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive Officer. Dr. Kutzer currently serves on Scorpion’s advisory board. Wed, 15 Jun 2022 11:39:00 GMT Yourway announces new flagship European Depot in Dublin, Ireland by <br/> <br/> Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, announced construction of a new flagship European depot in Dublin, Ireland. The new GMP facility is being purpose-built to support Yourway’s clinical trials offering, including premium courier services, primary and secondary packaging, and temperature-controlled storage from ambient room temperature (20°C) to liquid nitrogen (–180°C). Thu, 09 Jun 2022 06:19:00 GMT Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility by <br/> <br/> Manhattan, KS (USA) – April 26, 2022 –– Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates, which will support the construction of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas. Wed, 27 Apr 2022 07:17:00 GMT Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA by <br/> <br/> Allentown, PA (USA) – April 12, 2022 – Yourway, the only truly integrated premium courier and clinical packager in the clinical trials supply chain market, announced the expansion of its controlled ambient capabilities in Allentown, Pennsylvania. This expansion adds ~100,000 ft2 to Yourway’s existing extensive storage capabilities at its Allentown headquarters. The new location in Allentown is close to Yourway’s Global Headquarters and main storage facility, which is strategically located close to key airports, offering convenient global access to several domestic and international cities. Thu, 14 Apr 2022 12:23:00 GMT World Pharma Frontiers & LogiPharma 2022 Media partnership by <br/> <br/> Your only opportunity to learn from and network with the world’s pharmaceutical supply chain leaders. Thu, 17 Feb 2022 08:47:00 GMT Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene by <br/> <br/> Heilbronn & Heidelberg, Germany and Boston, USA – January 12, 2022: Following the announced merger in July 2021, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH today announced their unified operations and re-brand as ProtaGene, a world-leading CRO partner for the biopharmaceutical and cell & gene therapy industries. Thu, 13 Jan 2022 10:08:00 GMT Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC™ by <br/> <br/> OKLAHOMA CITY, OK, January 4, 2022 – (BUSINESS WIRE) – Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round. The round was co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation. Wed, 05 Jan 2022 13:45:00 GMT Watertown, MA (USA) – November 15, 2021 by <br/> <br/> Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services Tue, 16 Nov 2021 14:16:00 GMT TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility by <br/> <br/> NORWALK, Conn., Aug. 11, 2021/ -- TriRx Pharmaceutical Services, LLC, a leading international CDMO, hosted Kansas Lt. Governor David Toland, Shawnee Mayor Michelle Distler, State Senator Mike Thompson, Congresswoman Jo Ella Hoye, Congresswoman Cindy Neighbor, other Shawnee city leaders, representatives from The University of Kansas, Kansas State University, and key customers at a ribbon-cutting ceremony, Tuesday, August 10. Thu, 12 Aug 2021 10:30:00 GMT